Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany
Adolescent MenACWY vaccination in Germany has the potential to reduce the incidence and mortality of IMD, particularly from serogroups W and Y. Although the cost-effectiveness of the strategy depends on several assumptions, particularly the extent of carriage protection, the ICER for MenACWY introduction appears favorable.
Authors
- Wolfgang Greiner (ORCID: https://orcid.org/0000-0001-9552-6969)
- Oliver Damm (ORCID: https://orcid.org/0000-0003-0261-3655)
- Edith Langevin
- Moritz Wick (ORCID: https://orcid.org/0000-0003-3032-6354)
- Manuel Batram (ORCID: https://orcid.org/0000-0003-4445-965X)
- Sebastian Gruhn (ORCID: https://orcid.org/0000-0002-5291-650X)
- Stefan Scholz (ORCID: https://orcid.org/0000-0002-8421-8829)
Institutions
- Bielefeld University (DE)
- Hochschule Bielefeld (DE)
- Sanofi (France) (FR)
- Sanofi (Germany) (DE)
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1007/s40121-025-01132-3
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi-Aventis Deutschland